Skip to main content
Download PDF

Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results

Orphanet Journal of Rare Diseases volume 18, Article number: 55 (2023) Cite this article

The Original Article was published on 14 December 2022

Correction :  Orphanet Journal of Rare Diseases (2022) 17:437 https://doi.org/10.1186/s13023-022-02587-0

Following publication of the original article [1], we have been notified that Fig. 1 was published incorrectly. Correct Fig. 1 should be as per below:

Fig. 1
figure 1

Patient disposition

Full size image

Reference

  1. Diaz et al. Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results 2022;17:437. https://doi.org/10.1186/s13023-022-02587-0

Download references

Author information

Authors and Affiliations

  1. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY, 10029, USA

    George A. Diaz

  2. Medical Genetics Service HCPA, Department of Genetics UFRGS, DASA and Casa Dos Raros, Porto Alegre, Brazil

    Roberto Giugliani

  3. Reference Centre of Inherited Metabolic Disease in Femme Mère Enfant Hospital, Hospices Civils of Lyon, Lyon, France

    Nathalie Gufon

  4. Manchester University National Health Service Trust, St Mary’s Hospital, Manchester, UK

    Simon A. Jones

  5. Institute of Clinical Science for Lysosomal Storage Disorders, SphinCS GmbH, Mainz, Germany

    Eugen Mengel

  6. University Hospital of Udine, Udine, Italy

    Maurizio Scarpa

  7. University Hospitals Leuven, Louvain, Belgium

    Peter Witters

  8. Sanofi, Bridgewater, NJ, USA

    Abhimanyu Yarramaneni, Jing Li, Catherine Ortemann-Renon & Monica Kumar

  9. Sanofi, Cambridge, MA, USA

    Nicole M. Armstrong

  10. Sanofi, Paris, France

    Yong Kim

Authors
  1. George A. Diaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberto Giugliani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nathalie Gufon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Simon A. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eugen Mengel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maurizio Scarpa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Peter Witters
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Abhimanyu Yarramaneni
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Nicole M. Armstrong
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yong Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Catherine Ortemann-Renon
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Monica Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George A. Diaz.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diaz, G.A., Giugliani, R., Gufon, N. et al. Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results. Orphanet J Rare Dis 18, 55 (2023). https://doi.org/10.1186/s13023-023-02647-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13023-023-02647-z

Orphanet Journal of Rare Diseases

ISSN: 1750-1172